Home › Funds › Nexus Investment Management ULC › ABT

Nexus Investment Management ULC position in ABT

ABBOTT LABORATORIES · Health Care

Nexus Investment Management ULC reported holding 2,490 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$246K, representing 0.03% of its reported portfolio and ranking #43 among its reported holdings. Nexus Investment Management ULC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.49K sh
Reported value held$246.09K
Portfolio Weight0.03%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Nexus Investment Management ULC's ABT position evolved

Nexus Investment Management ULC first disclosed a stake in ABT in Q3 2023 at 3,290 shares (US$319K). The position peaked in Q1 2025 at 2,490 shares, worth US$475K. Across 13 filings, Nexus Investment Management ULC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 2,490 shares valued at US$246K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.29K $318.64K New
Q4 2023 3.29K $362.13K Hold
Q1 2024 3.29K $373.94K Hold
Q2 2024 3.29K $341.86K Hold
Q3 2024 3.29K $375.09K Hold
Q4 2024 2.49K $281.64K Reduce
Q1 2025 2.49K $475.11K Hold
Q2 2025 2.49K $338.67K Hold
Q3 2025 2.49K $333.51K Hold
Q4 2025 2.49K $311.97K Hold
Q1 2026 2.49K $255.65K Hold
Q2 2026 2.49K $225.94K Hold
Q3 2026 2.49K $246.09K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Nexus Investment Management ULC held ABT?

Nexus Investment Management ULC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Nexus Investment Management ULC's current position in ABT?

As of Q3 2026, Nexus Investment Management ULC holds 2.49K shares of ABT (ABBOTT LABORATORIES), valued at $246.09K, representing 0.03% of its reported portfolio and ranking #43.

Has Nexus Investment Management ULC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Nexus Investment Management ULC held unchanged its position in ABT. The position peaked in Q1 2025 at 2.49K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.